Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AAV5 vector
Description:
A recombinant adeno-associated virus serotype 5 vector used to transfer therapeutic genes into cells in gene therapy.
Primary topic:
Hemophilia Treatment and Research (34%)
Related topics:
Hemophilia Treatment and Research (34%),
Virus-based gene therapy research (26%),
Retinal Development and Disorders (12%),
Genetic Neurodegenerative Diseases (7%)
OpenAlex ID:
keywords/aav5-vector
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B
2019
·
Annette Von Drygalski
, Adam Giermasz
, et al.
·
Blood Advances
·
146
PDF
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
2016
·
Jana Miniarikova
, Ilaria Zanella
, et al.
·
Molecular Therapy — Nucleic Acids
·
144
PDF
AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
2017
·
J Miniarikova
, V Zimmer
, et al.
·
Gene Therapy
·
112
PDF
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A
2021
·
K John Pasi
, Michael Laffan
, et al.
·
Haemophilia
·
98
PDF
Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy
2005
·
Caroline Sevin
, Abdellatif Benraiss
, et al.
·
Human Molecular Genetics
·
98
A Single-Step Affinity Column for Purification of Serotype-5 Based Adeno-associated Viral Vectors
2001
·
Alberto Auricchio
, Erin O'Connor
, et al.
·
Molecular Therapy
·
96
PDF
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A
2020
·
Brian R. Long
, Philippe Veron
, et al.
·
Molecular Therapy
·
80
PDF
Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
2009
·
M.-A. Colle
, F. Piguet
, et al.
·
Human Molecular Genetics
·
79
Safety and Liver Transduction Efficacy of rAAV5- cohPBGD in Nonhuman Primates: A Potential Therapy for Acute Intermittent Porphyria
2013
·
Astrid Pañeda
, Esperanza Lopez-Franco
, et al.
·
Human Gene Therapy
·
67
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
2023
·
Annette von Drygalski
, Esteban Gomez
, et al.
·
Blood Advances
·
64
PDF
Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice
2011
·
Kai Qiu
, Darin J Falk
, et al.
·
Molecular Therapy
·
62
PDF
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
2019
·
Raygene Martier
, Marina Sogorb-Gonzalez
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
61
PDF
Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury
2020
·
Jarred M. Griffin
, Barbara Fackelmeier
, et al.
·
Experimental Neurology
·
43
PDF
Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy
2017
·
Yuxin Zhang
, Wen-Tao Deng
, et al.
·
Scientific Reports
·
42
PDF
First hemophilia B gene therapy approved: More than two decades in the making
2022
·
Roland W. Herzog
, Thierry VandenDriessche
, et al.
·
Molecular Therapy
·
40
IL-10 delivery by AAV5 vector attenuates inflammation in mice with pseudomonas pneumonia
2010
·
S M Buff
, H Yu
, et al.
·
Gene Therapy
·
39
A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease
2022
·
Anna Kotowska-Zimmer
, Lukasz Przybyl
, et al.
·
Molecular Therapy — Nucleic Acids
·
37
PDF
First CRISPR therapy dosed
2020
·
Nature Biotechnology
·
37
PDF
Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia
2018
·
Ron Ofri
, Edward Averbukh
, et al.
·
Human Gene Therapy
·
36
Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis
2015
·
Caroline J. Aalbers
, Lisette Bevaart
, et al.
·
PLoS ONE
·
36
PDF
Sustained Interleukin-10 Transgene Expression Following Intra-Articular AAV5-IL-10 Administration to Horses
2019
·
Kaitlyn L. Moss
, Zibin Jiang
, et al.
·
Human Gene Therapy
·
34
Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3 -Mutant Dogs
2017
·
Guo-jie Ye
, András M. Komáromy
, et al.
·
Human Gene Therapy Clinical Development
·
33
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease models
2024
·
Marina Sogorb-Gonzalez
, Christian Landles
, et al.
·
Brain
·
32
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A
2024
·
Brian R. Long
, Tara M. Robinson
, et al.
·
Molecular Therapy
·
31
Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo
2022
·
Suneel Gupta
, Michael K. Fink
, et al.
·
Molecular Therapy
·
28
Show more works
View as search
Works count:
123
Citation count:
1,884
Year
Topic
Type